<DOC>
	<DOC>NCT01833117</DOC>
	<brief_summary>The purpose of this study was to compare the effect of FID 119515A to Blink® Tears on the integrity of tear film in adults with a history of dry eye in both eyes.</brief_summary>
	<brief_title>Efficacy and Safety Study of FID 119515A</brief_title>
	<detailed_description>Subjects who met the enrollment criteria were randomized in a 2:1 manner to receive treatment with FID 119515A or Blink® Tears respectively for this 1-day, single-dose study.</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>Sign Informed Consent. Best corrected visual acuity (BCVA) of 55 or greater in each eye as measured by an ETDRS chart (letters read method). At least a 3 month documented history of dry eye in both eyes. TBUT and Ocular Surface Disease Index (OSDI) Questionnaire score as specified in protocol. Other protocoldefined inclusion criteria may apply. Pregnant or breastfeeding. Any evidence of ocular infection or inflammation within 30 days prior to Screening. Any ocular surgery. Ocular trauma requiring medical or pharmacological treatment within 1 year of Screening. Current presence of punctal plugs (permanent or temporary) or previous permanent punctal closure by cautery/diathermy. Use of topical ocular prescription or nonprescription medications within 30 days of Screening. Participation in any other clinical trial within 30 days prior to Screening. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Dry eye</keyword>
	<keyword>Tear film</keyword>
	<keyword>Tear break-up time</keyword>
	<keyword>Ocular surface</keyword>
	<keyword>Eye drops</keyword>
</DOC>